Agilent Technologies, Inc. A
172.79
(0.05)
(0.03%)
as of 25 Sep
- Market cap
- $49.0B
- P/E
- 33.9×
Follow A
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Agilent Technologies, Inc. (A) Net income
Agilent Technologies, Inc.'s net income for fiscal 2025 was $1.3B, unchanged from fiscal 2024. Over the twelve months to 31 July 2026 it was $1.4B. Over the past ten years it has ranged from $316.0M (fiscal 2018) to $1.3B (fiscal 2025) — the current reading is the highest in ten years. Agilent Technologies, Inc. ranks 3rd of 52 Diagnostics & Research companies by net income.
Net income, annual
Annual
| Period | Net income | Change |
|---|---|---|
| FY2025 | $1.3B | 1.09% |
| FY2024 | $1.3B | 3.95% |
| FY2023 | $1.2B | (1.12%) |
| FY2022 | $1.3B | 3.64% |
| FY2021 | $1.2B | 68.29% |
| FY2020 | $719.0M | (32.87%) |
| FY2019 | $1.1B | 238.92% |
| FY2018 | $316.0M | (53.80%) |
| FY2017 | $684.0M | 48.05% |
| FY2016 | $462.0M | 15.21% |
Quarterly
| Period | Net income | Change |
|---|---|---|
| Jul 2026 | $362.0M | 6.78% |
| Apr 2026 | $339.0M | 11.15% |
| Jan 2026 | $305.0M | (29.72%) |
| Oct 2025 | $434.0M | 29.17% |
| 43 more quarters | Free account |
Against its own ten years
Low $316.0M
High $1.3B
Ten-year median
$1.1B
Current reading's percentile
100
Net income against peers
| Company | Net income |
|---|---|
| A Agilent Technologies, Inc. | $1.4B |
| IQV IQVIA Holdings Inc. compare | $1.4B |
| IDXX IDEXX Laboratories, Inc. compare | $1.1B |
| DGX Quest Diagnostics Incorporated compare | $1.1B |
| MTD Mettler-Toledo International, Inc. compare | $905.6M |
| ILMN Illumina, Inc. compare | $824.0M |
| WAT Waters Corporation compare | $166.6M |
| NTRA Natera, Inc. compare | −$192.3M |
| GH Guardant Health, Inc. compare | −$453.4M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on A
- Revenue
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement